Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.6B | 14.6B | 16.4B | 13.3B |
Cost of revenue | 10.1B | 12.9B | 14.0B | 11.2B |
Gross profit | 476.7M | 1.8B | 2.4B | 2.0B |
Operating expense | ||||
Research & development | 97.4M | 533.1M | 430.5M | 240.8M |
Selling general and admin | 322.4M | 95.0M | 1.0B | -240.6M |
Other operating expenses | 72.2M | 150.5M | 89.8M | 74.0M |
Operating income | -5.4M | 566.0M | 1.4B | 1.5B |
Non operating interest income | ||||
Income | 22.3M | 35.3M | 35.8M | 49.6M |
Expense | 574.5M | -2.2B | 602.4M | 617.2M |
Other income expense | — | — | — | — |
Pretax income | -434.3M | -299.2M | 1.1B | 1.2B |
Tax provision | 46.9M | 20.2M | 236.2M | 275.2M |
Net income | -481.2M | -319.4M | 843.9M | 933.8M |
Basic EPS | -0.1 | — | — | — |
Diluted EPS | -0.1 | — | — | — |
Basic average shares | 4.8B | — | — | — |
Diluted average shares | 4.8B | — | — | — |
EBITDA | 140.0M | -2.1B | 1.7B | 1.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | 98.3M | -183.5M | -279.8M | -157.1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |